Dr. Stéphanie Proulx obtained her Ph.D. from the Université du Québec à Trois-Rivières in the Biophysics and cell biology program. She then pursued a post-doctoral internship at Laval University, where she developed an expertise in tissue engineering. Dr. Proulx is currently a researcher in the axis of regenerative medicine of the CHU de Québec-UL Research Center (St-Sacrement Hospital), an assistant Professor at the Laval University School of Medicine in the department of ophthalmology, and a researcher in the Center for research in experimental organogenesis of Laval University/LOEX. Dr. Proulx is also part of the board of directors of the Vision Health Research FRQS Network and the Cell and tissue therapy FRQS Network.
Understanding eye diseases using tissue engineering
The eye is a complex organ, and all its structures are important to have good vision. Despite advances in medicine, the causes of many eye diseases remain unclear. Using cell culture and tissue engineering, Dr. Proulx’s team developed three-dimensional models that allow to study the interactions that cells have between themselves, and with their environment. Comparing the models engineered with healthy cells with the models engineered using pathological cells, it is possible to advance our knowledge on the pathogenesis of various eye diseases. These models are also used to test different agents and for the development of new treatment strategies.
1050, chemin Sainte-Foy
CUO-Recherche
H2-04
Québec, Québec
Canada G1S 4L8
Latest news
- Anney, PrinciaDoctoral studentHôpital Saint-Sacrementprincia.anney@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
JS2-00 H2-00
Québec, QC
Canada G1S 4L8 - Charpentier, PascaleMaster studentHôpital Saint-Sacrementpascale.charpentier@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
JS2-00 H2-00
Québec, QC
Canada G1S 4L8 - Charpentier, PascaleEmployeeHôpital Saint-Sacrementpascale.charpentier@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
JS2-00 H2-00
Québec, QC
Canada G1S 4L8 - Coutant, KellyEmployeeHôpital Saint-Sacrement+1 418-682-7511, extension 84917kelly.coutant@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
JS2-05
Québec, QC
Canada G1S 4L8 - Gross, ChristelleEmployeeHôpital Saint-Sacrement+1 418-525-4444, extension 87872christelle.gross@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
JS2-08
Québec, QC
Canada G1S 4L8 - Karami, SamiraDoctoral studentHôpital Saint-Sacrementsamira.karami@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
Québec, QC
Canada G1S 4L8 - Sasseville, SamanthaMaster studentHôpital Saint-Sacrement+1 418-525-4444, extension 84919samantha.sasseville@crchudequebec.ulaval.ca
1050, chemin Sainte-Foy
JS2-00 / H2-00
Québec, QC
Canada G1S 4L8 - Tchatchouang, AngeDoctoral studentHôpital Saint-Sacrement+1 418-525-4444, extension 84917ange.tchatchouang@crchudequebec.ulaval.ca
1050 Chemin Sainte-Foy
JS2-04
Québec, QC
Canada G1S 4L8
Physiological pressure enhances the formation of tight junctions in engineered and native corneal endothelium
Journal ArticleExp Eye Res, 179 , 2019.
TGF-β1 promotes cell barrier function upon maturation of corneal endothelial cells
Journal ArticleSci Rep, 8 (1), 2018.
Extracellular Matrix and Integrin Expression Profiles in Fuchs Endothelial Corneal Dystrophy Cells and Tissue Model
Journal ArticleTissue Eng Part A, 24 (7-8), 2018.
Delayed transient corneal edema after intravitreal injection of ocriplasmin
Journal ArticleCan J Ophthalmol, 53 (2), 2018.
Function-Related Protein Expression in Fuchs Endothelial Corneal Dystrophy Cells and Tissue Models
Journal ArticleAm J Pathol, 188 (7), 2018.
Tissue engineering of a healthy corneal endothelium for FECD patients
Book ChapterCursiefen C (Ed.): Current Treatment Options for Fuchs Endothelial Dystrophy, pp. 237-255, Springer International Publishing, 2017, ISBN: 9783319430195.
Alternatives to eye bank native tissue for corneal stromal replacement
Journal ArticleProg Retin Eye Res, 59 , 2017.
Restoration of Mitochondrial Integrity, Telomere Length, and Sensitivity to Oxidation by In Vitro Culture of Fuchs' Endothelial Corneal Dystrophy Cells
Journal ArticleInvest Ophthalmol Vis Sci, 57 (14), 2016.
In Vivo Functionality of a Corneal Endothelium Transplanted by Cell-Injection Therapy in a Feline Model
Journal ArticleInvest Ophthalmol Vis Sci, 57 (4), 2016.
Characterization of a corneal endothelium engineered on a self-assembled stromal substitute
Journal ArticleExp Eye Res, 145 , 2016.
Active projects
- Cryo-TEM infrastructure for the visualisation of nanoparticles, exosomes and virus-like particles, from 2023-04-01 to 2024-03-31
- Fuchs endothelial corneal dystrophy and corneal transplantation: The traditional paradigm revisited, from 2019-10-01 to 2024-09-30
- Influence du TFG-ß et de l’environnent physique sur la formation des jonctions intercellulaires et la transition endothélio-mésenchymateuse, from 2018-04-01 to 2024-03-31
- Reformation d’un endothélium cornéen fonctionnel par injection cellulaire, from 2019-04-01 to 2024-03-31
- Rôle des mélanocytes choroïdiens dans la gestion du stress oxydatif des cellules de l’épithélium pigmentaire rétinien, from 2020-04-01 to 2023-08-30
- Utilisation de modèles cellulaires et tissulaires pour l'étude de maladies de l'oeil et du développement de nouvelles thérapies, from 2022-07-01 to 2025-06-30
Recently finished projects
- DMLA-Transitions , from 2022-01-31 to 2023-01-30
- Improving Corneal Endothelial Cell Adhesion, from 2017-07-01 to 2023-03-31
- Improving Corneal Endothelial Cell Adhesion, from 2018-04-01 to 2023-03-31
- New Functional Polymers for Next Generation Contact Lenses - a Phase I Project, from 2019-07-01 to 2022-06-30
- Projet pilote : génie tissulaire de l'endothélium cornéen sur un hydrogel mimiquant une membrane de Descemet, from 2021-02-15 to 2022-03-31
- Utilisation de modèles cellulaires et tissulaires pour l'étude de maladies de l'oeil et du développement de nouvelles thérapies, from 2019-07-01 to 2021-06-30